PROVIDER PROFILE · NPI 1356509947

Mark PankoninM.D./PH.D.

PRESCRIBING · PART D · 2024
Total Rx claims
654
Beneficiaries
Total drug cost
$206K
Distinct drugs
10
Brand share
64.5%
Top prescribed drugs
QUALITY · MIPS · 2024
No data available for this provider in 2024.